Our findings, in conjunction with previous studies, show that the signaling pathway involving IL22 and TGFB1 helps establish a microenvironment that promotes epithelial-mesenchymal transitions, malignancy progression, and tumor formation (22, 23, 50). The gene discussed is IL22; the disease is neoplasm.